annual EBIT:
-$156.32M+$340.59M(+68.54%)Summary
- As of today (July 1, 2025), APLS annual earnings before interest & taxes is -$156.32 million, with the most recent change of +$340.59 million (+68.54%) on December 31, 2024.
- During the last 3 years, APLS annual EBIT has risen by +$576.44 million (+78.67%).
- APLS annual EBIT is now -3779.42% below its all-time high of -$4.03 million, reached on December 31, 2013.
Performance
APLS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$80.83M-$56.30M(-229.49%)Summary
- As of today (July 1, 2025), APLS quarterly earnings before interest & taxes is -$80.83 million, with the most recent change of -$56.30 million (-229.49%) on March 31, 2025.
- Over the past year, APLS quarterly EBIT has dropped by -$21.55 million (-36.35%).
- APLS quarterly EBIT is now -190.10% below its all-time high of $89.72 million, reached on December 31, 2020.
Performance
APLS quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$177.87M-$21.55M(-13.78%)Summary
- As of today (July 1, 2025), APLS TTM earnings before interest & taxes is -$177.87 million, with the most recent change of -$21.55 million (-13.78%) on March 31, 2025.
- Over the past year, APLS TTM EBIT has increased by +$208.36 million (+53.95%).
- APLS TTM EBIT is now -6565.41% below its all-time high of -$2.67 million, reached on September 30, 2014.
Performance
APLS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
APLS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +68.5% | -36.4% | +54.0% |
| 3 y3 years | +78.7% | +37.4% | +73.9% |
| 5 y5 years | +47.8% | +51.0% | +60.9% |
APLS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.7% | -229.5% | +55.8% | -13.8% | +73.0% |
| 5 y | 5-year | at high | +78.7% | -190.1% | +62.5% | -13.8% | +75.7% |
| alltime | all time | -3779.4% | +78.7% | -190.1% | +62.5% | -6565.4% | +75.7% |
APLS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$80.83M(+229.5%) | -$177.87M(+13.8%) |
| Dec 2024 | -$156.32M(-68.5%) | -$24.53M(-44.6%) | -$156.32M(-26.1%) |
| Sep 2024 | - | -$44.32M(+57.3%) | -$211.54M(-29.5%) |
| Jun 2024 | - | -$28.18M(-52.5%) | -$299.92M(-22.3%) |
| Mar 2024 | - | -$59.29M(-25.7%) | -$386.23M(-22.3%) |
| Dec 2023 | -$496.92M(-19.7%) | -$79.75M(-39.9%) | -$496.91M(-13.9%) |
| Sep 2023 | - | -$132.69M(+15.9%) | -$576.89M(-8.0%) |
| Jun 2023 | - | -$114.50M(-32.6%) | -$627.11M(-4.9%) |
| Mar 2023 | - | -$169.97M(+6.4%) | -$659.65M(+6.6%) |
| Dec 2022 | -$618.88M(-15.5%) | -$159.72M(-12.7%) | -$618.88M(+2.5%) |
| Sep 2022 | - | -$182.92M(+24.4%) | -$603.72M(-1.7%) |
| Jun 2022 | - | -$147.04M(+13.8%) | -$614.08M(-10.0%) |
| Mar 2022 | - | -$129.19M(-10.6%) | -$682.47M(-6.9%) |
| Dec 2021 | -$732.76M(+134.0%) | -$144.56M(-25.2%) | -$732.76M(+47.0%) |
| Sep 2021 | - | -$193.29M(-10.3%) | -$498.48M(+15.6%) |
| Jun 2021 | - | -$215.42M(+20.0%) | -$431.39M(+31.7%) |
| Mar 2021 | - | -$179.48M(-300.0%) | -$327.67M(+4.7%) |
| Dec 2020 | -$313.09M | $89.72M(-171.1%) | -$313.09M(-38.9%) |
| Sep 2020 | - | -$126.20M(+13.0%) | -$512.10M(+12.5%) |
| Jun 2020 | - | -$111.71M(-32.3%) | -$455.12M(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$164.90M(+50.9%) | -$414.34M(+38.4%) |
| Dec 2019 | -$299.42M(+139.6%) | -$109.29M(+57.9%) | -$299.42M(+32.6%) |
| Sep 2019 | - | -$69.22M(-2.4%) | -$225.78M(+17.9%) |
| Jun 2019 | - | -$70.93M(+41.9%) | -$191.52M(+24.9%) |
| Mar 2019 | - | -$49.98M(+40.2%) | -$153.32M(+23.2%) |
| Dec 2018 | -$124.99M(+146.9%) | -$35.64M(+1.9%) | -$124.41M(+16.7%) |
| Sep 2018 | - | -$34.97M(+6.8%) | -$106.63M(+28.1%) |
| Jun 2018 | - | -$32.73M(+55.3%) | -$83.25M(+32.9%) |
| Mar 2018 | - | -$21.07M(+18.0%) | -$62.65M(+23.7%) |
| Dec 2017 | -$50.63M(+86.7%) | -$17.86M(+54.1%) | -$50.63M(+28.8%) |
| Sep 2017 | - | -$11.59M(-4.5%) | -$39.30M(+12.5%) |
| Jun 2017 | - | -$12.13M(+34.0%) | -$34.94M(+53.2%) |
| Mar 2017 | - | -$9.05M(+38.8%) | -$22.81M(+65.8%) |
| Dec 2016 | -$27.12M(+35.0%) | -$6.52M(-9.9%) | -$13.76M(-3.1%) |
| Sep 2016 | - | -$7.23M(+3.9%) | -$14.20M(+17.1%) |
| Dec 2015 | -$20.09M(+77.9%) | -$6.96M(+35.0%) | -$12.13M(+50.1%) |
| Sep 2015 | - | -$5.16M(+76.9%) | -$8.08M(+44.6%) |
| Dec 2014 | -$11.29M(+180.3%) | -$2.92M(+9.3%) | -$5.59M(+109.3%) |
| Sep 2014 | - | -$2.67M | -$2.67M |
| Dec 2013 | -$4.03M | - | - |
FAQ
- What is Apellis Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual EBIT year-on-year change?
- What is Apellis Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly EBIT year-on-year change?
- What is Apellis Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals TTM EBIT year-on-year change?
What is Apellis Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of APLS is -$156.32M
What is the all time high annual EBIT for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual earnings before interest & taxes is -$4.03M
What is Apellis Pharmaceuticals annual EBIT year-on-year change?
Over the past year, APLS annual earnings before interest & taxes has changed by +$340.59M (+68.54%)
What is Apellis Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of APLS is -$80.83M
What is the all time high quarterly EBIT for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly earnings before interest & taxes is $89.72M
What is Apellis Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, APLS quarterly earnings before interest & taxes has changed by -$21.55M (-36.35%)
What is Apellis Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of APLS is -$177.87M
What is the all time high TTM EBIT for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high TTM earnings before interest & taxes is -$2.67M
What is Apellis Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, APLS TTM earnings before interest & taxes has changed by +$208.36M (+53.95%)